Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

News Industry News

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

July 23, 2019

News Industry News

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

April 18, 2019

News Industry News

CMS Grants New Technology Add-on Payment to the remedē® System for the Treatment of Central Sleep Apnea

August 06, 2018

News Industry News

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

May 17, 2018

News Industry News

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

May 08, 2018

News Industry News

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

April 09, 2018

News Industry News

Baim Institute Names Dr. C. Michael Gibson As CEO

December 05, 2017

News Industry News

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

September 15, 2017

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Industry News

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

May 12, 2017

News Industry News

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

November 21, 2016

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

News Industry News

Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research

October 27, 2016

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

September 20, 2016

News Industry News

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

September 16, 2016

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Industry News

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

April 26, 2016

News Industry News

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

October 26, 2015

Advertisement

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

CMS Grants New Technology Add-on Payment to the remedē® System for the Treatment of Central Sleep Apnea

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

Baim Institute Names Dr. C. Michael Gibson As CEO

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content